IHC | Immunohistochemistry Market Report- Analysis Of Demand-Side Drivers And Opportunities | Danaher Corporation, PHC Holdings Corporation

The global immunohistochemistry market is projected to reach USD 2.7 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 6.6% during the forecast period.

The report also provides a comprehensive review of market drivers, restraints, challenges, and opportunities in the IHC market

The report segments the Immunohistochemistry Market based on region (Asia Pacific, Europe, North America, and RoW), product (antibodies, equipment, kits, and reagents), application (diagnostics, research, and forensic), and end user (hospitals & diagnostic laboratories, academic & research institutes, and other end users).

Get FREE PDF Sample of the report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=771785

Top Company Profile Analysis in this Report-
F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Sakura Finetek Japan Co., Ltd. (Japan), Abcam plc (UK), Becton, Dickinson and Company (US), Histo-Line Laboratories (Italy), Bio SB, Inc. (US), Diagnostic BioSystems (US), BioGenex (US), Bio-Rad Laboratories, Inc. (US), Biocare Medical, LLC. (US), Miltenyi Biotec (US), CANDOR Bioscience GmbH (Germany), EagleBio (US), Cell Signaling Technology, Inc. (US), Enzo Biochem Inc. (US), BioVision, Inc. (US), Elabscience, Inc. (China), Amos Scientific Pty Ltd. (Australia), Bio-Techne (US), and Jinhua YIDI Medical Appliance CO., LTD. (China)

The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market. However, the high degree of consolidation is expected to restrain the growth of this market during the forecast period

The antibodies segment includes primary antibodies and secondary antibodies. The primary antibodies segment accounted for the fastest growing IHC antibody market.  Factors such as improved approval rate for therapeutic antibodies by regulatory authorities, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies. Also, the mandatory use of primary antibodies in IHC protocols and their extensive application in diverse diagnostic and research areas have resulted in continuous demand for these antibodies.

Based on equipment type, the IHC equipment segment is further divided into slide-staining systems, tissue processing systems, slide scanners, and other equipment (automated cover slippers, microtomes, paraffin dispensers, tissue microarrays, and slide labelers). The slide-staining systems accounted for the largest share of IHC market, by equipment. Development of high-throughput staining systems is  one of the major factor driving  market growth.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the large population in emerging economies such as China, India, and Japan; rising prevalence of chronic diseases; rising demand for quality medical care; and the increasing healthcare spending are expected to boost the IHC market in the Asia Pacific.

North America accounted for the largest share of the IHC market. The large share of this segment can primarily be attributed to the to the presence of major players operating in the IHC market in the US, rising incidence of cancer and infectious diseases, and the increasing adoption of companion diagnostic assay kits.

Single User License: US $ 4950
Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=771785

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the IHC market and provides them information on key market drivers, restraints, challenges, and opportunities.

Table Of Contents in this Report-
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
1.7 Summary Of Changes

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
Figure 1 Breakdown Of Primaries: Immunohistochemistry Market
2.1.3 Market Data Estimation & Triangulation
2.1.4 Data Triangulation
Figure 2 Data Triangulation Methodology
2.2 Market Estimation Methodology
Figure 3 Market Size Estimation: Approach 1 (Company Revenue Analysis-Based Estimation)
Figure 4 Immunohistochemistry Market Size (Usd Billion)
Figure 5 Immunohistochemistry Market: Final Cagr Projections (2020−2025)
Figure 6 Immunohistochemistry Market: Cagr Projections From The Analysis Of Demand-Side Drivers And Opportunities
2.3 Industry Insights
2.4 Research Assumptions

3 Executive Summary
Figure 7 Immunohistochemistry Market, By Product, 2020 Vs. 2025 (Usd Million)
Figure 8 Immunohistochemistry Market Share, By Application, 2019
Figure 9 Immunohistochemistry Market, By End User, 2020−2025
Figure 10 Geographical Snapshot Of The Immunohistochemistry Market

4 Premium Insights
4.1 Immunohistochemistry Market Overview
Figure 11 Technological Advancements To Drive Market Growth
4.2 Asia Pacific: Immunohistochemistry Market Share, By End User And Country (2019)
Figure 12 Hospitals & Diagnostic Laboratories Segment Accounted For The Largest Share Of The Asia Pacific Ihc Market In 2019
4.3 Immunohistochemistry Antibodies Market, By Type
Figure 13 Primary Antibodies Segment Will Continue To Dominate The Ihc Antibodies Market In The Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 14 Immunohistochemistry Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Growing Incidence And Prevalence Of Cancer
Figure 15 Cancer Incidence, By Region And Type Of Cancer, 2018
5.2.1.2 Technological Advancements In Ihc
5.2.1.3 Availability Of Reimbursements For Ihc Tests
Table 1 Cpt Codes For Ihc Procedures
5.2.2 Restraints
5.2.2.1 High Degree Of Consolidation
Table 2 Major Acquisitions In The Market, 2015–2020
5.2.3 Opportunities
5.2.3.1 Increasing Demand For Personalized Medicine
5.2.4 Challenges
5.2.4.1 Dearth Of Skilled Professionals
Table 3 Number Of Pathologists Per 100,000 Population, By Country, 2018
5.2.4.2 Product Failures And Recalls
5.3 Impact Of Covid-19 On The Immunohistochemistry Market

and more...

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.